INTRODUCTION
============

Due to their high cost, noble or semi-noble alloys with high content of gold and palladium, represent a problem when used to produce fixed prostheses over implants. Alternatively, newly developed alloys attempt to reduce corrosion without risk of losing the right physical properties. The different metallic materials used in such alloys have yielded varied results. Solá *et al*. \[[@R1]\] analysed resistance to corrosion of four noble alloys (Pontor 2^®^, Cerapall 2^®^, V-Gnathos Plus^®^ and Pagalin^®^) and of a titanium alloy (Ti6Al4V) attached to commercially pure titanium (c.p. Ti). These authors observed a differential resistance to corrosion depending on the composition of each of the alloys used, despite the fact that all of them largely contain gold and palladium. For their part, as it has been shown, gold and palladium-based alloys present a lower dissolution rate and therefore greater corrosion resistance than those made up of non-noble base metals such as nickel- chrome or chrome-cobalt \[[@R2]-[@R6]\]. In order to improve corrosion resistance and "make them nobler" Sarantopoulos \[[@R7]\] studied two alloys (*Noble Crown*^®^ *and Noble Crown NF*^®^) made with the last two pairs of non-noble metals to which palladium was added, thus he concluded that the inclusion of this element has deleterious effects upon the physico-chemical properties of both alloys. Furthermore, Poljak-Guberina \[[@R8]\] pointed out the need to study processes which may enable to line or coat non-noble materials with higher corrosion-resistance ones, which will improve the behaviour of these alloys in the oral environment. Electro-chemical corrosion is the most important injury factor in dental work. It produces unintended wear of the metal surface, and a deterioration of the outer and inner layers caused by exposure to chemicals or electrochemical reaction of the surrounding area \[[@R9]\].

Given the nature of the medium in the oral cavity, it is especially important that the materials used show a high electrolytic corrosion resistance. The consequences of corrosion in alloys for dental use may result in negative biological, functional and aesthetic effects, of which the biological ones have higher significance. During corrosive processes, metal ions are freed into the medium and come into contact with neighbouring tissues and/or are spread throughout the entire body. Biological incompatibility of these ions can produce body injury, causing toxicity and risk of sensitization; therefore, it is fundamental the use of alloys made up of metals with a low degree of ionic \[[@R10]\].

Titanium properties make it ideal for use in dental implants, and it has been used successfully in dentistry for many years \[[@R4]\]. Its high resistance to corrosion results from the formation of a thin highly-adhesive layer of titanium oxide, being at the same time extremely biocompatible. However, one of the main problems of using titanium in the manufacturing of prosthetic structures results from the difficulty in handling it during the casting process.

According to the A.D.A. (*American Dental Association*) \[[@R11]\] classification system, noble alloys consist of at least 25% gold or metals of the platinum group.

Precious alloys (of high gold, silver, palladium and platinum content) are usually implemented as bases for fixed metal-ceramic prostheses. Compared to titanium or stainless steel alloys, precious alloys are distinguished by a high corrosion resistance (significantly increased when containing more than 75% gold \[[@R12]\]) as well as a low-to-moderate mechanical resistance.

Due to their low electrochemical stability, non-noble alloys or base metal alloys (Cr-Ni) combined with c.p. titanium, show a high corrosion level. Therefore, their implementation is contraindicated in the manufacturing of prosthetic suprastructures over implants. In an *in vitro* study of corrosion on alloys that are in contact with titanium \[[@R3]\], it was observed that those alloys based on non--noble metals (Cr-Co, Cr-Ni) present a higher dissolution rate than alloys based on noble metals (Au, Pd).

*Argen^®^* Corporation developed *Noble Bond^®^* alloy, which is made up of 75% base metals and 25% ruthenium, the latter also belonging to the group of noble metals (*Noble Bond^®^* Alloy -Composition: Ruthenium 25%, Cobalt 40%, Chrome 24%, Gallium 11%, Boron lines).

The purpose of producing this alloy is to improve the base metals alloys (Cr-Co) resistance to corrosion and, at the same time, to offer a low cost material with electrochemical characteristics similar to those of the noble alloys.

The success of noble alloys with high content of gold, palladium and c.p. titanium in the production of prosthetic structures over implant--supported suprastructure \[[@R3], [@R13], [@R14]\] is well known because of both their biocompatibility and their resistance to corrosion. These are the reasons that led to a comparative analysis regarding the effects of electrolytic corrosion on two types of noble alloys: *Argelite 76sf+^®^* (*Argen^®^*) and *Noble Bond^®^* (*Argen^®^*) and c.p. titanium.

The main purpose of this study was to determine if the *Noble Bond^®^* alloy is an electrochemically suitable material to make prosthetic suprastructures over c.p. titanium implants.

Besides, the following aspects were analysed:

-   Degree of electrolytic corrosion caused by the *Noble Bond^®^* alloy in combination with c.p. titanium;

-   Degree of electrolytic corrosion caused by an alloy with high content of gold in combination with c.p. titanium;

-   Degree of electrolytic corrosion caused by c.p. titanium over implants and abutment.

-   A comparison of the results obtained for the three metals / alloys used in the implant-supported suprastructure.

MATERIALS AND METHODOLOGY
=========================

In this prospective experimental study 15 *ad modum* transmucosal abutments (UCLA type) of 4.1 mm diameter coupled with 15 implants made of IV--degree titanium of 4 mm diameter and 10 mm length were used (*B&W*^®^ Buenos Aires, Argentina).

Five out of the 15 abutments were castings that used *Noble Bond^®^* alloy (Trial Group 1 = TG 1); other five were castings that used *Argelite 76sf+*^®^ noble alloy (Composition: Gold 1.8%, Palladium 75.7%, Ruthenium below 1%, Indium 8%, Gallium 6.3%, Tin below 1%, Copper 7.5%, Borium below 1%) (Trial Group 2 = TG 2); and the remaining five were abutments made in c.p. titanium (*B&W*^®^ Buenos Aires, Argentina) (Control Group = CG).

Sample Preparation and Casting
------------------------------

All the cast samples were prepared from castable plastic cylinder abutments and for the c.p. titanium samples machined straight abutments (*B&W*^®^ Buenos Aires, Argentina) were used.

The device used was a compact benchtop vacuum pressure casting machine with integrated power cooling and touch display Nautilus T from BEGO with Lolipot crucibles (Bremen, Germany). To avoid oxidation processes, casting was performed in new crucibles by induction in controlled atmosphere, following the specifications provided by each of the alloys' manufacturers. Once the UCLA abutments were cast, they were sand-blasted with non-recycled aluminium oxide- particle size 50 microns- at 60 psi, in order to remove oxide and lining remains.

Sample polishing was carried out with diamond rubber points and polishing paste following one direction and according to the manufacturer's specifications for both alloys. Finally, samples were decontaminated by immersion in distilled water and in ultrasonic cleaner for 10 minutes, procedure recommended by the manufacturers to remove polishing remains.

Fixation of prosthetic components on implants was carried out using c.p. titanium screws (*B&W*^®^ Buenos Aires, Argentina) torqued at 35 N. Once the samples were obtained, they were placed in plastic containers and labeled (Fig. **[1](#F1){ref-type="fig"}**).

Sample Analysis and Treatment
-----------------------------

Each sample was analysed using a confocal microscope (*OLYMPUS^®^LEXT OLS4000 3D Laser Measuring Microscope*), designed to obtain nanometric images, 3D measurements and to measure roughness levels. The images obtained correspond to three different zones analysed (Fig. **[2](#F2){ref-type="fig"}**):

1.  Abutment Neck (U Neck).

2.  Implant Neck (I Neck).

3.  Implant Body (I Body).

The following 3D metric parameters were obtained in each of the photographed areas:

1.  **Sa:**  *Arithmetical mean height of the surface*.

2.  **Sp:**  *Maximum height of peaks*.

3.  **Sv:**  *Maximum height of valleys*.

After labeled, samples were placed in plastic containers and immersed in modified Ericsson solution as artificial saliva whose behaviour is quite similar to that of natural saliva and is generally used in electrolytic corrosion studies (composition: NaCl= 0.600 / KCl = 0.720 / CaCl~2~.2H~2~O = 0.220 / KH~2~PO~4~ = 0.680 / Na~2~HPO~4~.12H~2~O = 0.856 / KSCN = 0.060 / KHCO~3~ = 1.500 / Citric acid = 0.030) \[[@R15]\].

Samples were kept immersed in the containers for three months, at the end of which, samples were analysed again using the same procedures applied at the beginning of the study (Fig. **[3](#F3){ref-type="fig"}**). The electrolyte was not changed during exposure.

An analytical technique by static immersion with an increased immersion time \[[@R12], [@R15]\] and in accordance with ISO/ TR 10271:1993 was the methodology used for sample treatment.

Statistical Analysis
--------------------

Parametric data obtained (*Sa*, *Sp* and *Sv*) in all samples, before and after immersing them in artificial saliva, were subjected to statistical treatment by running an ANOVA, LSD Fisher Alfa Test, and Tukey's Alfa Test.

RESULTS
=======

The tables below show the metric parameters obtained through the images of the samples studied, before and after artificial saliva immersion (Tables **[1](#T1){ref-type="table"}**-**[6](#T6){ref-type="table"}**).

Sa; Arithmetical Mean Height of the Surface
-------------------------------------------

Although in the *abutment neck* (U Neck) *Argelite^®^* alloy showed a decrease of the Sa after saliva immersion, this variation was not significant. No statistically significant differences were found for the other two alloys Sa values at this level. The analysis of the Sa at the level of the *implant neck* (I Neck) showed no statistically significant differences on its surface in combination with the three studied alloys.

Similar results were found for the surface of the *implant body* (I Body) in contact with the three studied alloys, even though a slight increase of the Sa in the *Argelite*^®^ noble alloy was observed, differences were not statistically significant (Fig. **[4](#F4){ref-type="fig"}**).

Sp, Maximun Height of Peaks
---------------------------

As for Sp values in the *implant neck* (I Neck), although there was a decrease in values, the observed changes in the three samples, before and after immersion in artificial saliva, were not significant at the statistical level.

In the *implant neck* (I Neck) Sp values remained much the same.

As for Sp values in the *implant body* (I Body), an increase of this value was observed in the c.p. titanium alloy and a decrease of this same value in the *Argelite*^®^ one; however, the differences found were not statistically relevant. In the case of *Noble Bond^®^*, no statistically significant differences were found (Fig. **[5](#F5){ref-type="fig"}**).

Sv, Maximun Height of Valleys
-----------------------------

In the *abutment neck* (U Neck), a slight decrease in the Sv values in the *Noble Bond^®^* alloy was observed, but it was not statistically significant. No significant differences were found in the *Argelite^®^* alloy or in c.p. titanium.

Comparing the results before and after artificial saliva immersion, no differences were observed at the level of the *implant neck* (I Neck) in any of the three alloys. Comparing results in the *implant body* (I Body) area, a slight increase in the *Argelite^®^* alloy values was observed after immersion, but neither this increase nor the values obtained with the other two alloys were statistically significant (Fig. **[6](#F6){ref-type="fig"}**).

An example of pre and post submersion of the samples is shown in Fig. (**[7](#F7){ref-type="fig"}**)

DISCUSSION
==========

All metals used in devices for biomedical prostheses degrade to a greater or lesser extent \[[@R4]\]. The purpose of this study was to determine if *Noble Bond^®^* alloy was a biomaterial electrochemically suitable to manufacture prosthetic suprastructures over c.p. titanium implants.

Adding a noble metal to non--noble alloys has already been done by *Argen^®^* company in *Noble Crown NF*^®^ (Co-Pd-Cr-A) alloy and *Noble Crown*^®^ (Ni-Pd-Cr) alloy. Although these alloys showed an increase in their nobility, they worsened the resistance to corrosion in comparison to the conventional Co-Cr and Ni-Cr--base alloys from an *in vitro* study performed by Sarantopoulos *et al*. \[[@R7]\]. Unlike these results, in the present study and after immersion in artificial saliva for three months, there were no signs of corrosion at the alloy's surface level when ruthenium instead of palladium was used.

Regarding titanium abutments and titanium implants combined with the different alloys, no statically differences were observed between values obtained before and after immersing the samples in artificial saliva. This behaviour coincides with the one reported by other authors. Meffert *et al*. and Botha *et al*. concluded that initial rust gives titanium high resistance to corrosion, making it inert to tissues, and its low density provides it with a high resistance / weight relation making it highly biocompatible \[[@R16], [@R17]\].

Using titanium alloys to manufacture prosthetic suprastructures over implants avoids the problem of galvanic corrosion. A study carried out by Arismendi *et al*. \[[@R3]\] suggests that the best combination restoration--implant for trial conditions can be achieved by using c.p. titanium and a titanium alloy. Besides, titanium is considered one of the most corrosion-resistant materials used for biomedical purposes \[[@R5], [@R16], [@R18]\]. Two characteristics of titanium make it ideal for dental implants: its high mechanical resistance and its spontaneous passivation when in contact with water, air or tissue fluids \[[@R11]\].

The stable behaviour observed in noble alloys coincides with the results obtained in studies performed by other authors who concluded that noble alloys with high content of gold and palladium combined with c.p. titanium implants present high resistance to corrosion with minimum release of the metal's ions to the medium, as they develop a passivation mechanism when in contact with the medium \[[@R3], [@R5], [@R14]\]. Palladium-based alloys without silver show a rather passive behaviour and better than the Pd-Ag alloys \[[@R12]\]. Similarly, Cortada \[[@R9]\], in a galvanic corrosion study, concluded that palladium--based alloys present low levels of ions release in combination with titanium. In addition, it was shown that resistance to corrosion in silver--palladium based alloys is compatible with alloys with high contents of gold studied in artificial saliva \[[@R3], [@R5], [@R14]\]. In the present study there was no significant surface modification (Sa, Sp, and Sv) of the samples at U neck, I neck or I body when *Argelite^®^* alloy was used.

The methodology applied to treat the samples consists in an analytical technique through static immersion under ISO/TR 10271:1993 standards. The only variation introduced was an increase in the period of samples immersion \[[@R12], [@R19]\]. Further *in vitro* studies with longer periods of samples immersion in artificial saliva and *in vivo* studies are recommended.

CONCLUSION
==========

No statistically significant differences between experimental *Noble Bond^®^* alloy, noble alloy and c.p. titanium alloys were found in the present study as regards electrogalvanic corrosion, measured through tridimensional changes that took place on the surface of the samples (Sa, Sp, and Sv) three months after having been immersed in artificial saliva, both at abutment level or at implant neck and body levels. Further research on longer periods of immersion is necessary to validate these preliminary results.
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###### 

Data obtained from the Titanium-Titanium group before immersion in artificial saliva.

  **Sample**   **Sector**               ***Sa***   ***Sp***   ***Sv***
  ------------ ------------------------ ---------- ---------- ----------
  1            Abutment Neck (U Neck)   0.079      1.788      4.428
               Implant Neck (I Neck)    0.098      1.299      1.546
               Implant Body (I Body)    0.384      7.887      7.07
  2            Abutment Neck (U Neck)   0.043      1.507      0.988
               Implant Neck (I Neck)    0.059      0.903      0.872
               Implant Body (I Body)    0.478      6.787      6.649
  3            Abutment Neck (U Neck)   0.046      6.295      2.024
               Implant Neck (I Neck)    0.09       3.028      2.045
               Implant Body (I Body)    0.446      5.801      12.234
  4            Abutment Neck (U Neck)   0.042      2.461      2.813
               Implant Neck (I Neck)    0.196      2.775      4.318
               Implant Body (I Body)    0.458      6.974      9.166
  5            Abutment Neck (U Neck)   0.062      3.712      4.258
               Implant Neck (I Neck)    0.06       1.862      1.18
               Implant Body (I Body)    0.587      8.533      11.863

###### 

Data obtained from the Titanium-*Argelite^®^* group before immersion in artificial saliva.

  **Sample**   **Sector**               ***Sa***   ***Sp***   ***Sv***
  ------------ ------------------------ ---------- ---------- ----------
  6            Abutment Neck (U Neck)   0.039      1.955      0.809
               Implant Neck (I Neck)    0.172      5.266      3.567
               Implant Body (I Body)    0.345      8.564      14.786
  7            Abutment Neck (U Neck)   0.042      4.226      1.565
               Implant Neck (I Neck)    0.11       3.12       3.222
               Implant Body (I Body)    0.361      14.215     12.9
  8            Abutment Neck (U Neck)   0.038      3.178      1.883
               Implant Neck (I Neck)    0.157      2.879      2.921
               Implant Body (I Body)    0.542      12.845     13.927
  9            Abutment Neck (U Neck)   0.229      4.729      3.563
               Implant Neck (I Neck)    0.179      2.468      2.042
               Implant Body (I Body)    0.394      19.706     15.759
  10           Abutment Neck (U Neck)   0.392      8.676      6.768
               Implant Neck (I Neck)    0.217      7.422      5.841
               Implant Body (I Body)    0.538      9.46       12.604

###### 

Data obtained from the Titanium-*Noble Bond^®^* group before immersion in artificial saliva.

  **Sample**   **Sector**               ***Sa***   ***Sp***   ***Sv***
  ------------ ------------------------ ---------- ---------- ----------
  11           Abutment Neck (U Neck)   0.071      6.126      16.417
               Implant Neck (I Neck)    0.114      1.998      1.892
               Implant Body (I Body)    0.459      8.046      11.115
  12           Abutment Neck (U Neck)   0.068      3.795      1.675
               Implant Neck (I Neck)    0.157      2.231      3.305
               Implant Body (I Body)    0.54       8.858      9.216
  13           Abutment Neck (U Neck)   0.057      1.283      3.266
               Implant Neck (I Neck)    0.112      2.097      2.564
               Implant Body (I Body)    0.512      7.298      7.57
  14           Abutment Neck (U Neck)   0.072      13.389     4.293
               Implant Neck (I Neck)    0.117      3.959      5.794
               Implant Body (I Body)    0.575      16.041     16.991
  15           Abutment Neck (U Neck)   0.046      2.328      2.235
               Implant Neck (I Neck)    0.118      2.013      2.486
               Implant Body (I Body)    0.556      7.962      9.815

###### 

Data obtained from the Titanium-Titanium group after immersion in artificial saliva.

  **Sample**   **Sector**               ***Sa***   ***Sp***   ***Sv***
  ------------ ------------------------ ---------- ---------- ----------
  1            Abutment neck (U neck)   0.075      1.48       1.178
               Implant neck (I neck)    0.071      2.141      3.927
               Implant body (I body)    0.342      4.836      10.087
  2            Abutment neck (I neck)   0.048      2.04       1.23
               Implant neck (U neck)    0.062      2.774      4.923
               Implant body (I body)    0.504      14.755     14.682
  3            Abutment neck (U neck)   0.046      1.097      6.274
               Implant neck (I neck)    0.051      2.512      0.93
               Implant body (I body)    0.486      10.274     10.177
  4            Abutment neck (U neck)   0.046      1.527      0.858
               Implant neck (I neck)    0.092      1.837      1.326
               Implant body (I body)    0.476      10.758     13.079
  5            Abutment neck (U neck)   0.058      1.251      1.282
               Implant neck (I neck)    0.06       0.907      0.997
               Implant body (I body)    0.565      6.804      12.324

###### 

Data obtained from the Titanium-*Argelite*^®^ group after immersion in artificial saliva.

  **Sample**   **Sector**               ***Sa***   ***Sp***   ***Sv***
  ------------ ------------------------ ---------- ---------- ----------
  6            Abutment neck (U neck)   0.051      1.535      1.454
               Implant neck (I neck)    0.171      3.706      3.366
               Implant body (I body)    0.432      5.802      15.634
  7            Abutment neck (I neck)   0.046      1.938      1.913
               Implant neck (U neck)    0.119      4.068      4.883
               Implant body (I body)    0.48       7.681      10.358
  8            Abutment neck (U neck)   0.035      3.261      2.863
               Implant neck (I neck)    0.15       2.949      2.387
               Implant body (I body)    0.635      6.566      16.501
  9            Abutment neck (U neck)   0.034      3.389      1.469
               Implant neck (I neck)    0.186      3.955      4.319
               Implant body (I body)    0.621      7.662      23.614
  10           Abutment neck (U neck)   0.036      2.359      2.52
               Implant neck (I neck)    0.158      4.507      3.914
               Implant body (I body)    0.621      15.512     17.969

###### 

Data obtained from the Titanium-*Noble Bond^®^* group after immersion in artificial saliva.

  ***Sample***   ***Sector***             ***Sa***   ***Sp***   ***Sv***
  -------------- ------------------------ ---------- ---------- ----------
  11             Abutment neck (U neck)   0.068      0.739      1.001
                 Implant neck (I neck)    0.116      4.692      2.518
                 Implant body (I body)    0.558      7.161      12.144
  12             Abutment neck (I neck)   0.084      7.859      2.979
                 Implant neck (U neck)    0.152      3.847      4.119
                 Implant body (I body)    0.398      8.454      16.652
  13             Abutment neck (U neck)   0.083      3.338      3.905
                 Implant neck (I neck)    0.126      3.379      4.021
                 Implant body (I body)    0.64       8.798      10.924
  14             Abutment neck (U neck)   0.043      0.933      4.239
                 Implant neck (I neck)    0.096      2.216      2.862
                 Implant body (I body)    0.513      8.797      8.22
  15             Abutment neck (U neck)   0.05       1.949      0.69
                 Implant neck (I neck)    0.129      2.905      2.261
                 Implant body (I body)    0.546      8.558      13.799
